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This study reports the results from 3 European 
centers using rotary ablation with RotabiatorTM, a 
device that is inserted into the coronary artery 
and removes atheroma by grinding it into millions 
of tiny fragments. Rotary abtation was performed 
in 129 patients. Primary success (reduction in 
percent iuminai narrowing >20%, restduai steno- 
sis <SO%, without complications) was achieved by 
rotary angiopiasty alone in 73 patients (57%). An 
additional 38 patients (29%) had successful ad- 
junctive balloon angiopiasty. Thus primary suc- 
cess was achieved in 111 patients (86%) at the 
end of the procedure. Acute occlusion occurred in 
10 patients (7.7%). Recanaiization was achieved 
by balloon angiopiasty in 7: urgent bypass graft- 
ing was undertaken in 2. Q-wave and non-Q-wave 
myocardiai infarction occurred in 3 and 7 pa- 
tients, respectively. No deaths occurred. Foilow- 
up angiography was performed in 74 patients 
(60%). Restenosis, defined as the recurrence of 
significant luminal narrowing (>50%) occurred in 
17 of 37 patients (46%) who underwent rotary ab- 
lation alone, and 11 of 37 patients (30%) who had 
adjunctive balloon angiopiasty. The overall angio- 
graphic restenosis rate was 37.80/o. in conclusion, 
rotary ablation is technically feasible, and reiative- 
iy safe in the coronary circulation. The low pri- 
mary success rate reflects the limited size of the 
device, which can be introduced through available 
guiding catheters, and limits the use of rotary ab- 
lation as a stand-alone procedure to lesions in 
small arteries or in distal locations. No reduction 
in restenosis was seen, but the role of this device 
combined with balloon angiopiasty in larger arter- 
ies needs to be further defined. 
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T he original description of percutaneous translu- minal coronary angioplasty has led to major changes in the clinical practice of cardiology, and 
has stimulated innovative xpression i  research. In the 
last 5 years, significant improvements have been made 
in the initial balloon catheter system described by 
Gruentzig et al.’ However, the major problem of reste- 
nosis, which occurs in up to 40% of cases after an ini- 
tially successful procedure,* and continuing technical 
difficulties in dealing with certain types of lesion (par- 
ticularly those that are calcified or in distal locations) 
have stimulated research into alternative methods of 
dealing with atheromatous coronary obstructions. One 
such technique, coronary atherectomy, has been devel- 
oped to produce an improvement in lumen diameter by 
direct mechanical removal of atherosclerotic material 
from the vessel wall in situ. Several techniques for this 
purpose have been described including directional (or 
excisional) atherectomy, transluminal extraction ather- 
ectomy, and high speed rotary ablation. In this study, 
we present he results obtained in 3 European centers 
using high-speed rotary ablation with RotablatoP. 
METHOD5 
The Rotablator (Heart Technology, Inc., Bellvue, 
Washington) consists of an abrasive tip (Figure 1) 
welded to a long flexible drive shaft tracking along a 
central flexible guidewire. The abrasive tip is an ellipti- 
cally shaped burr, manufactured in various sizes (from 
1 .O mm to 2.75 mm in diameter), whose distal portion is 
coated with diamond chips 30 to 50 p in diameter. Ro- 
tational energy is transmitted by a disposable com- 
pressed air motor that drives the flexible helical shaft at 
very high speeds (up to 190,000 rpm). The number of 
revolutions per minute is measured by a fiberoptic light 
probe and displayed on a control panel. The speed of 
rotation is controlled by the air pressure, which is itself 
controlled by the operator using a foot pedal. During 
rotation, a small volume of sterile saline solution irri- 
gates the catheter sheath to lubricate and cool the rotat- 
ing parts. The burr and the drive shaft move freely over 
a central coaxial guide wire (0.009 inch in diameter), 
with a flexible radioopaque platinum distal part (20 mm 
long), which does not rotate with the burr during abra- 
sion. This central guidewire can be controlled and 
moved with a pin vise. The wire and the abrasive tip can 
be advanced independently, which allows the wire to be 
placed in a safe distal location before the burr is ad- 
vanced into the diseased artery. 
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Protoeolr All patients received nifedipine (60 mg 
orally in 3 divided doses) and aspirin (500 mg orally) 
the day before the procedure. Chlorodiazepate (50 mg 
intravenously) was given on the day of the procedure as 
premeditation. A sheath (9Fr) was inserted into the 
femoral artery under local anesthesia nd a standard 
9Fr guiding catheter was advanced to the ostium of the 
coronary artery. After intracoronary injection of isosor- 
bide dinitrate (2 mg), a baseline angiogram was record- 
ed in 3 projections, and heparin (10,000 IU) was given 
intravenously. 
Rotary ablation began with the placement of the 
small guidewire across the lesion to a safe distal vessel 
location, sometimes guided by a 3Fr infusion catheter 
which was positioned first. The burr and the drive shaft 
were then manually advanced over the guidewire to the 
site of the lesion, and rotation was begun. When an ade- 
quate speed of rotation (>lSO,OOO rpm) had been 
achieved, the abrasive tip was advanced gently over the 
guidewire. If resistance was encountered the tip was 
successively pulled back and advanced to maintain a 
high speed of rotation. Several slow passes were usually 
required to achieve maximal plaque removal. Typical 
results of the procedure are shown in Figures 2 and 3. 
The angiographic results of the patients tudied in Lille 
and Rotterdam were assessed by computerized quanti- 
tative coronary angiography (as described later). When 
the residual stenosis after atherectomy remained signifi- 
cant (>50%), an additional percutaneous balloon angio 
plasty was performed. Patients were discharged with ni- 
fedipine (60 mg/day) and aspirin (100 to 500 mg/day) 
and underwent repeat coronary angiography 3 to 6 
months after the procedure. The study protocol was ap 
proved by the local Research Ethics Committee, and 
written informed consent was obtained from all pa- 
tients. 
Primary success of rotary ablation was defined as a 
significant reduction (>20%) of stenosis with residual 
stenosis <50% without complications during hospital- 
ization. Restenosis was defined as the recurrence of a 
significant narrowing (reduction of luminal diameter 
>50%). 
Study population: One hundred twenty-nine patients 
(107 men and 22 women, mean age 57 f 8 years, range 
33 to 68) underwent rotary ablation. Sixty-five patients 
were treated in Lille, France, 54 in Mainz, Germany, 
and 10 in Rotterdam, the Netherlands. 
Clinical characteristics: Most of the patients (n = 
68 or 53%) had severe (Canadian Cardiovascular Grade 
3) stable effort angina, 13 or 10% had angina on effort 
and at rest, 15 (11.5%) had unstable angina, 15 com- 
plained of angina at rest, and only 6 (5%) had atypical 
chest pain; finally, 12 patients had no chest pain. 
flGURE1.GistalpartoftheRotabWor withtheburr. 
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TABLE I Quantitative Coronary Analysis After Rotary Ablation 
Rotary Ablation 
After Rotary 
Ablation Before After + Balloon 
Rotary ablation (mm) 0.72 f 0.30 1.46 2 0.43 
Stand alone proce- 73 + 12 42 t 13* 
dure (%I 
Rotary ablation + balloon 
angioplasty 
mm 0.49 + 0.37 1.14 k 0.36* 2.2 -+ 0.46* 
% 80 k 12 61 * 13 31 f 9* 
*p <O.Ol. 
Quantitative coronary angiography: coronary ar- 
dilated vessel to the narrowest point of the stenosis on 
teriograms were analyzed with use of a computer- 
ized automatic-analysis ystem (Computerized Assisted 
Evaluation of Stenosis and Restenosis). The tine film 
was projected with a Tagarno projector and the end- 
diastolic frame selected for analysis was scanned with a 
CCD JVC video camera. The signal produced by the 
video camera was digitized and processed with a soft- 
ware system on a 386 computer provided with an auto- 
matic edge-detection algorithm. The diameter of the 
coronary catheter was used to convert he imaging data 
from pixels to millimeters. The frames for analysis were 
chosen by a cardiologist who was not involved in the 
study protocol. The dilated vessel segment was defined 
by measuring the distance from a side branch of the 
l-, 2- and 3-vessel disease in 68, 25 and 7%, respective- 
Angiographic data: Coronary angiograms howed 
ly. In all patients only 1 coronary segment was treated 
by rotary ablation. The procedure was performed on the 
left anterior descending artery in 63 patients, the right 
coronary artery in 47 patients and the circumflex artery 
in the remaining 19 patients. Most of the stenoses were 
routine lesions: According to American Heart Associ- 
ation/American College of Cardiology classification, 
48% of the patients had type A lesions; types B and C 
were observed in 36 and 16% respectively. Twenty-six 
lesions were calcified. 
the angiogram immediately before ablation. All mea- 
surements were performed on angiograms recorded af- 
ter the intracoronary injection of 2 mg of isosorbide di- 
nitrate. 
Statistical analysis: All data are expressed as mean 
f SD. Comparisons between vessel diameters (or per- 
centage reduction in luminal diameter) before rotary 
ablation, immediately after rotary ablation and at fol- 
low-up were performed with use of paired Student’s t
tests. A p value <0.05 was considered statistically sig- 
nificant. 
nGURE3.R~dslstionwitha?.Smmbwrofamkl-kft~or~ ksion. Upper pane/s, before Rotablator; Lw- 
er pads, after Rotablator. 
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RESULTS 
Rotary ablation was performed in 128 patients; in 1 
patient the guidewire could not be passed across a very 
tight and tortuous stenosis. Rotary ablation as a stand- 
alone procedure was achieved in 88 patients; in 40 pa- 
tients, rotary ablation was completed by adjunctive bal- 
loon angioplasty because of abrupt closure in 10 and 
insufficient results in 30 who still had significant steno- 
sis after the procedure. Thus, primary success was 
achieved by rotary ablation alone in 73 patients (57%). 
This relatively low success rate was mainly the result of 
the small size of the channel created by rotary ablation. 
This was due to the limited size of the burr acceptable 
for guiding catheters available at the beginning. With 
the help of additional successful balloon angioplasty in 
40 patients the overall success rate of 86% (111 of 129 
patients) was at the end of the procedure. 
Complications: A transient (few seconds) bradycar- 
dia was observed early in our experience in 6 patients. 
In 3 patients this occurred during a procedure on the 
right coronary artery and may have been related to mi- 
croembolization of the atrioventricular nodal artery. In 
all subsequent treatment of the right coronary artery a 
pacing catheter was placed in the right ventricle before 
the procedure. Immediately after the procedure 8 pa- 
tients developed a long diffuse coronary spasm distal to 
the treated site, which was promptly relieved by the 
intracoronary injection of isosorbide dinitrate. Abrupt 
closure occurred during the procedure in 10 patients 
(7.8%): In 7, the lesion was easily recrossed with a bal- 
loon, 2 required rapid bypass surgery without further 
complications or infarction, and in 1 recanalization of 
the abrupt closure was not attempted because the area 
supplied by the vessel was relatively small (no increase 
in cardiac enzymes and no subsequent complications oc- 
curred in this particular patient). Three patients devel- 
oped late occlusion (at 6 hours, 24 hours and 6 days 
after the procedure). Myocardial infarction (Q wave in 
3, non-Q-wave in 7) developed in 10 patients (7.8%). 
Except for these 10 patients, serial creatine kinase mea- 
surements never exceeded the upper normal imit. There 
were no deaths related to the procedure. 
Quantitative angiographic measurements: Before 
and immediately after rotary ablation, quantitative an- 
giographic measurements (as previously outlined) were 
performed in the patients studied in Lille and Rotter- 
dam (n = 69). The results of rotary ablation as a stand- 
alone procedure are outlined in Table I. The mean mini- 
mal lumen diameter increased from 0.72 f 0.30 mm 
before to 1.46 f 0.43 mm immediately after the proce- 
dure (p <O.OOl). The ratio minimal luminal diameter/ 
burr size was 0.7 f 0.25. The mean percent reduction in 
internal uminal diameter decreased from 73 f 12 to 42 
f 13%. Where the procedure was completed by adjunc- 
tive balloon angioplasty the mean residual minimal di- 
ameter was 2.2 & 0.46 mm, and the mean residual per- 
cent stenosis was 31 f 990. 
Angiographic follow-up: Seventy-four patients un- 
derwent repeat coronary angiography at a mean of 4.6 
months (range 3 to 6) after the procedure. The angio- 
graphic results at follow-up were analyzed in 2 groups 
of patients: group A (n = 37) underwent rotary ablation 
as a stand-alone procedure and group B (n = 37) under- 
went rotary ablation with adjunctive balloon angio- 
plasty. Seventeen patients (46%) in group A had typical 
restenosis. In group B, restenosis was observed in 29.7% 
of patients. For the whole group the restenosis rate was 
37.8%. 
DISCUSSION 
The main mechanism of action of Rotablator is an 
abrasion of the occlusive material allowing restoration 
of lumen patency. The diamond chips on the burr re- 
move material in millions of tiny particles. Previous ex- 
perimental studies in animals, and observations made on 
segments of human iliac arteries treated with rotary an- 
gioplasty showed that the resulting arterial lumen was 
smooth and polished. 
Two major concerns have been expressed regarding 
the use of rotary ablation in the coronary circulation; 
one relates to its potential to damage adjacent nonath- 
eromatous tissue, the other to the size of the particles 
generated by the procedure. Studies in animals and in 
human peripheral arteries3-’ have shown that rotary ab- 
lation selectively removes firmer noncompliant material, 
while the normal elastic tissue is deflected away from 
the probe. This potential for selective removal of dis- 
eased tissue, with particular affinity for harder material 
such as calcium, is obviously of great clinical relevance. 
The removal of the endothelium may contribute to the 
occurrence of vasospasm which we observed in some pa- 
tients. However, in our patients vasospasm was usually 
seen 2 or 3 cm beyond the site of ablation and may have 
been related to vibrations transmitted to the guidewire 
during rotation of the burr. A similar phenomenon has 
been reported by Hansen5 after rotational atherectomy 
in a rabbit model of atheroma. 
No-flow phenomenon, transient bradycardia and 
atrioventricular blocks may be related to production of 
microcavitations. As a result of high velocity at the 
burr, surface cavitations are produced according the 
Bernoulli equation, and this was previously documented 
in experimental studies.8 
The second concern relates to the size of particles 
created by rotary ablation. This concern has been inves- 
tigated in several animal models6 and in human periph- 
eral arteries. These observations suggest hat the debris 
generated by rotary ablation is usually small enough to 
pass safely through the capillary bed. Moreover, in 32 
cases we assessed left ventricular motion before and af- 
ter rotary ablation and we did not observe wall motion 
abnormality after rotary ablation. 
The size of the burr used in the coronary artery is a 
limitation of the Rotablator. The device must be insert- 
ed in the coronary artery through a guiding catheter. 
However, even with the largest available guiding cathe- 
ters, the inside luminal diameter does not exceed 2.5 
mm. Thus, although burrs are available in sizes up to 
4.5 mm, only those <2.5 mm in diameter can be used in 
the coronary circulation. Moreover, the ratio residual 
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minimal lumen diameter/burr diameter is only 0.7: this 
suggests that the “effective abrasive diameter” is inferi- 
or to the maximal diameter of the burr. It is very likely 
that at the end of abrasion, the elastic arterial wall de- 
flects away, allowing the passage of the device through 
the lesion. From these experimental observations and 
our early clinical experience 2 different strategies may 
be adopted. One approach would be to start with an 
intentionally undersized burr, with stepwise increments 
in size until an optimal result is obtained. The other 
would involve the use of a small burr to “debulk” the 
vessel, leaving a smooth residual surface, and to com- 
plete the procedure with conventional balloon angio- 
plasty but using a very low inflation pressure. The re- 
sults in our patients would support this second ap 
preach. Until further information from comparative 
studies and longer follow up data are available, the role 
of rotary ablation in the treatment of coronary disease 
remains to be defined. The available evidence suggests 
that high-speed rotary ablation appears to be most use- 
ful for (1) lesions in vessels of 2.2 to 2.8 mm in diame- 
ter, (2) lesions in distal locations, (3) calcified or non- 
distensible lesions, and (4) eccentric lesions. However, 
its use should be avoided in patients with (1) lesions in 
large coronary vessels (>3.7 mm), (2) lesions in vessels 
with angiographically apparent hrombus, and (3) le- 
sions in degenerated saphenous vein grafts where the 
atherosclerotic material is likely to be friable. 
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